Price Watch

Coverage Dropped? Every Replacement Channel Compared for Ex-Insured Patients

77% of large employers are squeezing GLP-1 costs. For patients mid-treatment, the replacement question is continuity, not just price.

With 77% of large employers telling Mercer that managing GLP-1 costs is extremely or very important, coverage losses have become a routine event — and they hit differently than a new-patient decision. You're mid-treatment, at a working dose, with momentum to protect. Here's every replacement channel compared through that lens.

Replacement channels, ranked for mid-treatment continuity
ChannelMonthly costContinuity fit for ex-insured patients
Brand pen via TrumpRx/NovoCare$199 (sema) / $299 (tirz)Best — identical product you were on; just re-route fulfillment
Hybrid: cheap visit + brand channel$199–$299 + one visit feeBest if your prescriber was tied to the old plan
Flat-rate compounded$49 first mo → $99–$199Good — same molecule, compounded; provider manages transition
Budget compounded$99–$133Good — biggest savings; same-molecule continuity
Generic liraglutideLowest in classWeakest — different drug, daily dosing, step-down in effect

The Continuity-First Logic

If you were on brand Wegovy or Zepbound: the direct-pay brand channel is the gold-standard replacement — the literal same product at $199/$299. Your only tasks are re-routing the prescription and absorbing the new line item. If your prescriber came with the old insurance, the hybrid (one inexpensive telehealth visit for the prescription, then brand fulfillment) restores the full setup for one modest fee.

If $199–$299 doesn't fit the post-coverage budget: same-molecule compounded programs preserve pharmacological continuity at $99–$149 — a provider-supervised transition rather than an interruption. Disclose your current dose so you're continued at maintenance, not restarted.

Generic liraglutide is the floor, and for ex-insured patients specifically it's the weakest fit: a different, daily drug with more modest effect is a genuine step-down mid-journey. It's the right answer only when budget is the binding constraint — as a bridge, it beats a gap.

Hybrid Visit Component

Sesame Care

Brand-name route — Rybelsus, oral Wegovy, and injectable brand GLP-1s via low-cost doctor visits.

Flat-rate visits · brand-name FDA-approved medications only

  • FDA-approved brand-name medications only
  • Fast video visits in most states
  • Pairs well with $199 direct-pay channels
Visit Sesame Care
Same-Molecule, Flat Rate

Telos Rx (Semaglutide)

Flat-rate injectable semaglutide — the same price at starter dose and max dose.

Injectable compounded semaglutide — $49 first month on 12-mo plan · $99/mo (6-mo) · $129/mo (3-mo) · $199 month-to-month, flat at any dose

  • No dose-based price increases
  • Commitment length sets your rate
  • Consult and shipping included

Compounded medications are not FDA-approved. They are prepared by licensed pharmacies but have not been evaluated by the FDA for safety, effectiveness, or quality.

Visit Telos Rx (Semaglutide)
Deepest Same-Molecule Savings

GobyMeds

The lowest injectable price point we currently track.

Injectable compounded semaglutide $99/mo · tirzepatide $133/mo

  • Among the lowest injectable prices tracked
  • Direct pharmacy model
  • Flat monthly pricing

Compounded medications are not FDA-approved. They are prepared by licensed pharmacies but have not been evaluated by the FDA for safety, effectiveness, or quality.

Visit GobyMeds
Timing beats everything: the coverage end-date is your deadline, not your start date. Refill maximally before it hits, and have the replacement channel's prescription issued while the old benefits still exist. A two-week overlap costs little; a two-week gap costs re-titration.
Our verdict: for mid-treatment patients, rank replacements by continuity first — brand direct-pay if it fits the budget, same-molecule compounded if it doesn't, liraglutide only as a deliberate budget bridge. And execute before the deadline, not after it.

Bottom Line

Losing coverage in 2026 changes your invoice, not your access. Pick the channel that keeps your molecule and your dose intact, secure it before the benefits lapse, and the benefits committee's decision becomes a line-item annoyance instead of a treatment event.

Last updated August 2026. Verify current pricing; coordinate any medication transition with a licensed provider.

See the Full Comparison Grid

Every provider and channel we track — price, format, and what's included — side by side.

Compare All Providers

More Comparisons

Every Channel Ranked by Price

Switching Without a Treatment Gap

TrumpRx vs. Telehealth: Total Cost

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All prescription medications discussed require evaluation by a licensed healthcare provider. Always consult your doctor before starting, stopping, or changing any medication. Individual results vary.

Affiliate Disclosure: CompareGLP-1 may earn a commission when you use links on this page, at no additional cost to you. Links marked "Paid link" are sponsored. Our comparisons are editorially independent — rankings and verdicts are never sold, and we never fabricate statistics, testimonials, or reviews.